Response to letter to the Editors—Safety of long-term denosumab therapy

被引：0
|
作者：
Alison T. Stopeck
Douglas J. Warner
机构：
[1] Stony Brook University,Stony Brook Cancer Center
[2] Amgen Inc.,undefined
来源：
Supportive Care in Cancer | 2017年 / 25卷
关键词：
Prostate Cancer; Zoledronic Acid; Zoledronic; Denosumab; Cutoff Date;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：353 / 355
页数：2
相关论文
共 50 条
  • [1] Response to letter to the Editors-Safety of long-term denosumab therapy
    Stopeck, Alison T.
    Warner, Douglas J.
    [J]. SUPPORTIVE CARE IN CANCER, 2017, 25 (02) : 353 - 355
  • [2] Safety of long-term denosumab therapy for osteoporosis
    Compston, Juliet
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (07): : 485 - 487
  • [3] Long-term consequences of osteoporosis therapy with denosumab
    Bandeira, Francisco
    de Oliveira, Lucian Batista
    Bilezikian, John P.
    [J]. ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2022, 66 (05): : 717 - 723
  • [4] Short or Long-term Osteoporosis Therapy With Denosumab?
    Ferrari, Serge
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (04): : E1760 - E1762
  • [5] SHORT- AND LONG-TERM DENOSUMAB THERAPY
    Ferrari, S.
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S580 - S580
  • [6] Observations following discontinuation of long-term denosumab therapy
    McClung, M. R.
    Wagman, R. B.
    Miller, P. D.
    Wang, A.
    Lewiecki, E. M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2017, 28 (05) : 1723 - 1732
  • [7] Observations following discontinuation of long-term denosumab therapy
    M. R. McClung
    R. B. Wagman
    P. D. Miller
    A. Wang
    E. M. Lewiecki
    [J]. Osteoporosis International, 2017, 28 : 1723 - 1732
  • [8] Denosumab as a long-term palliative therapy in parathyroid carcinoma
    Tong, C. V.
    Loh, L. T.
    Hussein, Z.
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2017, 110 (01) : 55 - 55
  • [9] LONG-TERM EFFICACY AND SAFETY OF DENOSUMAB IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS
    Papapoulos, S. E.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 411 - 412
  • [10] Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab
    Anastasilakis, Athanasios D.
    Toulis, Konstantinos A.
    Polyzos, Stergios A.
    Anastasilakis, Chrysostomos D.
    Makras, Polyzois
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2012, 8 : 295 - 306
12345